Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/37286
Title: Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
Authors: 
Mesh: 
Issue Date: 2018
Citation: Br. J. Cancer.2018 04;(118)8:1056-1061
Abstract: Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. Outpatients with cancer should be periodically assessed for VTE risk, for which the Khorana score is commonly recommended. However, it has been questioned whether this tool is sufficiently accurate at identifying patients who should receive thromboprophylaxis. The present work proposes a new index, TiC-Onco risk score to be calculated at the time of diagnosis of cancer, that examines patients' clinical and genetic risk factors for thrombosis.
PMID: 29588512
URI: https://hdl.handle.net/20.500.12530/37286
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos
Hospitales > H. U. de Fuenlabrada > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5931103.pdf291.51 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.